---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-007971"
form_type: "8-K"
ticker: null
cik: "0001355250"
company_name: "Innovation Pharmaceuticals Inc."
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T05:42:46.731760+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Innovation Pharmaceuticals changes independent auditor from Pinnacle to GreenGrowth CPAs

## Summary
- On October 29, 2023, the Audit Committee dismissed Pinnacle Accountancy Group as the company's independent auditor, effective immediately.
- The company engaged GreenGrowth CPAs as its new independent public accounting firm on the same date.
- The change followed the sale of a portion of Pinnacle's public company accounting practice to GreenGrowth.
- Pinnacle's reports for fiscal years ended June 30, 2023 and 2022 were unqualified except for a going concern explanatory paragraph.
- The company reported a material weakness in internal control over financial reporting related to an unconsolidated foreign investment.

## SEC filing metadata
- accession: 0001477932-23-007971
- form_type: 8-K
- cik: 0001355250
- company_name: Innovation Pharmaceuticals Inc.
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/0001477932-23-007971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/ipix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-007971
- JSON: https://secwatch.observer/filing/0001477932-23-007971.json
- Plain text: https://secwatch.observer/filing/0001477932-23-007971.txt

## Key facts
- Auditor Changes
  Innovation Pharmaceuticals Inc. dismissed Pinnacle Accountancy Group of Utah (a d/b/a of Heaton & Company, PLLC) as its auditor.
  - Action: dismissal
  - Auditor: Pinnacle Accountancy Group of Utah (a d/b/a of Heaton & Company, PLLC)
  source text: On October 29, 2023, the Audit Committee of the Board of Directors of Innovation Pharmaceuticals Inc. (the "Company") dismissed Pinnacle Accountancy Group of Utah (a d/b/a of Heaton & Company, PLLC) ("Pinnacle") as the Company's independent public accounting firm
  evidence_url: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/0001477932-23-007971-index.htm
- Auditor Changes
  Innovation Pharmaceuticals Inc. engaged GreenGrowth CPAs as its auditor.
  - Action: engagement
  - Auditor: GreenGrowth CPAs
  source text: Also on October 29, 2023, the Audit Committee approved the engagement of GreenGrowth CPAs ("GreenGrowth") as the Company's new independent public accounting firm
  evidence_url: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/0001477932-23-007971-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.